Marcos J G De Lima

43PUBLICATIONS
217CO-AUTHORS
Molecular targetsRespiratory diseasesCardiology (incl. cardiovascular diseases)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 14, 2026
Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.

|Mar 02, 2026
BET inhibition blunts antibody production and macrophage-mediated fibrosis to restore lung function in murine cGVHD.

Rathan Kumar, Lotus Neidemire-Colley, Elizabeth Ar Garfinkle

|Feb 23, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Sumithira Vasu, Nathan Denlinger, No-Joon Song

|Sep 19, 2025
Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation.

Cooper Quartermaine, Zach Braunstein, Adnan Shaaban

|Jul 07, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis.

Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil

|Mar 20, 2025
CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant-A Podcast.

Marcos de Lima, David I Marks

Pageof 8

Frequent Collaborators

12 joint publications

Partow Kebriaei

10 joint publications

Mark R Litzow

8 joint publications

Vijaya Raj Bhatt

8 joint publications

Daniel Weisdorf